Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control

Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10057-62. doi: 10.1073/pnas.94.19.10057.

Abstract

Members of the NF-kappaB/Rel and inhibitor of apoptosis (IAP) protein families have been implicated in signal transduction programs that prevent cell death elicited by the cytokine tumor necrosis factor alpha (TNF). Although NF-kappaB appears to stimulate the expression of specific protective genes, neither the identities of these genes nor the precise role of IAP proteins in this anti-apoptotic process are known. We demonstrate here that NF-kappaB is required for TNF-mediated induction of the gene encoding human c-IAP2. When overexpressed in mammalian cells, c-IAP2 activates NF-kappaB and suppresses TNF cytotoxicity. Both of these c-IAP2 activities are blocked in vivo by coexpressing a dominant form of IkappaB that is resistant to TNF-induced degradation. In contrast to wild-type c-IAP2, a mutant lacking the C-terminal RING domain inhibits NF-kappaB induction by TNF and enhances TNF killing. These findings suggest that c-IAP2 is critically involved in TNF signaling and exerts positive feedback control on NF-kappaB via an IkappaB targeting mechanism. Functional coupling of NF-kappaB and c-IAP2 during the TNF response may provide a signal amplification loop that promotes cell survival rather than death.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Apoptosis / physiology*
  • Gene Expression Regulation / physiology
  • Humans
  • Inhibitor of Apoptosis Proteins
  • Jurkat Cells
  • NF-kappa B / physiology*
  • Transcription, Genetic / physiology
  • Tumor Necrosis Factor-alpha / physiology*
  • Viral Proteins / genetics
  • Viral Proteins / physiology*

Substances

  • Inhibitor of Apoptosis Proteins
  • NF-kappa B
  • Tumor Necrosis Factor-alpha
  • Viral Proteins
  • inhibitor of apoptosis, Nucleopolyhedrovirus